Target intelligence / Profile preview

Hemostatic mechanical matrix

Molecular classification
Other (medical device/biomaterial), Not a molecular target, enzyme, receptor, channel, or transporter
01

Overview

Hemostatic mechanical matrices are medical devices or biomaterials used to control bleeding by providing a physical scaffold that promotes blood clot formation. They work by absorbing blood and concentrating platelets and clotting factors at the site of bleeding, facilitating the body's natural hemostatic processes. Common types include gelatin sponges (e.g., Gelfoam, Surgifoam), microfibrillar collagen (Avitene), and microporous polysaccharide spheres (Arista). These agents are particularly useful when conventional methods are insufficient or when coagulopathies are present, and some may be used in combination with topical thrombin or fibrin sealants for enhanced clot formation. While generally safe and effective, complications such as foreign body reactions, infection, delayed resorption, or local tissue compression can occur if not used properly. These products do not occupy a molecular pathway targeted by drugs but rather provide a platform for physiologic hemostasis through mechanical means.

Other names
Hemostatic matrixMechanical hemostatHemostatic agent (mechanical)Hemostatic deviceMechanical hemostatic agent
02

Mechanism of action

Provides a physical matrix to concentrate platelets and blood proteins; Absorbs blood and fluid, swelling to fill wound space and support clotting; Exposes large surface area for platelet aggregation; May act as a scaffold for fibrin polymerization; Does not act through specific molecular inhibition or receptor activation

03

Biological functions

HemostasisMechanical support of clot formationPhysical barrier to bleedingPromotion of platelet aggregation at site of injury
04

Disease associations

Bleeding disordersSurgical bleedingTraumaAnticoagulation-related bleedingOther (general hemostasis support across diseases requiring bleeding control)
05

Safety considerations

Foreign body reactionInfection risk (rare, as most products are bioresorbable/bioinert)Compression of adjacent structures if used improperlyDelayed resorption or tissue necrosis, especially in confined spacesNot suitable for intravascular use (risk of embolism)
06

Interacting drugs

Thrombin (used in combination products such as fibrin sealants)

1 more in the full profile.

07

Biomarkers

Platelet function (indirectly relevant)Coagulation factors (relevance depends on patient context)There are no direct molecular biomarkers for matrix efficacy

Beyond the preview

Go deeper on Hemostatic mechanical matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemostatic mechanical matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call